Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.44 |
| ▸ | AGXT | P21549 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | GSK3B | P49841 | 2/20 | 0.40 |
| ▸ | BACE1 | P56817 | 2/20 | 0.40 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.34 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | KDM5A | P29375 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7792899 | 0.84 | ALDH1A1 (0.62) | IDO1ALDH1A1MAOBMAPK8MEN1 | |
| SCHEMBL7789774 | 0.81 | MAOB (0.41) | IDO1AGXTALDH1A1MAOBMAPK8 | |
| SCHEMBL7792926 | 0.80 | MAOB (0.46) | IDO1AGXTMAOB | |
| SCHEMBL7793842 | 0.76 | IDO1 (0.43) | IDO1AGXTMAOBGSK3BBACE1 | |
| SCHEMBL7792917 | 0.72 | NPC1 (0.51) | — | |
| SCHEMBL7347119 | 0.70 | RAB9A (0.54) | AGXTALDH1A1MAOBMAPK8 | |
| SCHEMBL30148003 | 0.67 | MAPK8 (0.52) | IDO1AGXTMAOBMAPK8 | |
| SCHEMBL1115269 | 0.67 | MAPK8 (0.52) | IDO1AGXTMAOBMAPK8 | |
| SCHEMBL6668911 | 0.66 | IDO1 (0.58) | IDO1AGXTALDH1A1MAOBGSK3B | |
| SCHEMBL15255521 | 0.66 | IDO1 (0.58) | IDO1AGXTALDH1A1MAOBGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010044547-A1 | Antiviral protease inhibitors | MEDIVIR AB | 2001-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010044547-A1 | Antiviral protease inhibitors | PEPD, PREP, CTSL | IDO1 564/4885AGXT 543/4885ALDH1A1 1578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.